| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |